Form 4 for HCWB HCW Biologics Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-21-067740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-01 | HCWB | Flowers Lee | SVP of Business Development | M - OptEx | $0.14 | +4,285 | 96.0K | +5% | +$599.90 |
| D | 2021-12-03 | 2021-12-01 | HCWB | Flowers Lee | SVP of Business Development | M - OptEx | $0.00 | -4,285 | 12.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | M | A | 4,285 | $0.14 | 95,952 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-01 | M | D | 4,285 | $0.00 | 12,857 | D | $0.14 · — to 2029-12-18 | 4,285 Common Stock | (F1) 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023. |